BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16418202)

  • 1. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.
    Tan FK; Zhou X; Mayes MD; Gourh P; Guo X; Marcum C; Jin L; Arnett FC
    Rheumatology (Oxford); 2006 Jun; 45(6):694-702. PubMed ID: 16418202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
    Bohgaki T; Amasaki Y; Nishimura N; Bohgaki M; Yamashita Y; Nishio M; Sawada KI; Jodo S; Atsumi T; Koike T
    Ann Rheum Dis; 2005 Aug; 64(8):1165-73. PubMed ID: 16014681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and lupus: points in an interferon-mediated continuum.
    Assassi S; Mayes MD; Arnett FC; Gourh P; Agarwal SK; McNearney TA; Chaussabel D; Oommen N; Fischbach M; Shah KR; Charles J; Pascual V; Reveille JD; Tan FK
    Arthritis Rheum; 2010 Feb; 62(2):589-98. PubMed ID: 20112391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
    Farutin V; Kurtagic E; Pradines JR; Capila I; Mayes MD; Wu M; Manning AM; Assassi S
    Arthritis Res Ther; 2021 Oct; 23(1):259. PubMed ID: 34654463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.
    Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Beri R; Corrocher R; Puccetti A
    PLoS Med; 2006 Jan; 3(1):e2. PubMed ID: 16318412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts.
    Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC
    J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Qin B; Huang F; Liang Y; Yang Z; Zhong R
    J Gastroenterol Hepatol; 2013 Mar; 28(3):543-50. PubMed ID: 23173724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F; Maul GG; Jiménez SA; Artlett CM
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
    Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers.
    Bos CL; van Baarsen LG; Timmer TC; Overbeek MJ; Basoski NM; Rustenburg F; Baggen JM; Thiesen HJ; Dijkmans BA; van der Pouw Kraan TC; Voskuyl AE; Verweij CL
    Genes Immun; 2009 Apr; 10(3):210-8. PubMed ID: 19129850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
    Beretta L; Barturen G; Vigone B; Bellocchi C; Hunzelmann N; De Langhe E; Cervera R; Gerosa M; Kovács L; Ortega Castro R; Almeida I; Cornec D; Chizzolini C; Pers JO; Makowska Z; Lesche R; Kerick M; Alarcón-Riquelme ME; Martin J; ;
    Ann Rheum Dis; 2020 Sep; 79(9):1218-1226. PubMed ID: 32561607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.
    Zhou X; Tan FK; Xiong M; Arnett FC; Feghali-Bostwick CA
    Arthritis Rheum; 2005 Oct; 52(10):3305-14. PubMed ID: 16200604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
    Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
    Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.
    Giusti B; Fibbi G; Margheri F; Serratì S; Rossi L; Poggi F; Lapini I; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Gensini GF; Del Rosso M; Abbate R
    Arthritis Res Ther; 2006; 8(4):R115. PubMed ID: 16859528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.
    Bellocchi C; Beretta L; Wang X; Lyons MA; Marchini M; Lorini M; Carbonelli V; Montano N; Assassi S
    Rheumatology (Oxford); 2023 Apr; 62(4):1662-1668. PubMed ID: 36040182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.
    Tan FK; Hildebrand BA; Lester MS; Stivers DN; Pounds S; Zhou X; Wallis DD; Milewicz DM; Reveille JD; Mayes MD; Jin L; Arnett FC
    Arthritis Rheum; 2005 Mar; 52(3):865-76. PubMed ID: 15751056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.